Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
Clinical trial NCT03363334 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03363334
- Sponsor
- Rigel Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.